Effectiveness and safety of Ivermectin in COVID‐19 patients: A prospective study at a safety‐net hospital-Reference-Cited by-同舟云学术

Effectiveness and safety of Ivermectin in COVID‐19 patients: A prospective study at a safety‐net hospital

Published:2021-11-29 Issue: Volume: Page:
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Ozer Muhammet¹^ORCID,Goksu Suleyman Yasin²,Conception Reena³,Ulker Esad¹,Balderas Rodolfo Magallanes¹,Mahdi Mohammed¹,Manning Zulfiya¹,To Kim³,Effendi Muhammad³,Anandakrishnan Rajashree⁴,Whitman Marc⁴,Gugnani Manish⁵

Affiliation:

1. Department of Internal Medicine Capital Health Medical Center Trenton New Jersey USA

2. Department of Internal Medicine UT Southwestern Medical Center Dallas Texas USA

3. Department of Pharmacology Capital Health Medical Center Trenton New Jersey USA

4. Department of Infectious Diseases Capital Health Medical Center Trenton New Jersey USA

5. Department of Pulmonology and Critical Care Capital Health Medical Center Trenton New Jersey USA

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27469

Reference17 articles.

1. Safety of high‐dose ivermectin: a systematic review and meta‐analysis;Navarro M;J Antimicrob Chemother,2020

2. Broad‐spectrum agents for flaviviral infections: dengue, Zika and beyond;Boldescu V;Nat Rev Drug Discovery,2017

3. Ivermectin is a specific inhibitor of importin α/β‐mediated nuclear import able to inhibit replication of HIV‐1 and dengue virus;Wagstaff KM;Biochem J,2012

4. The FDA‐approved drug ivermectin inhibits the replication of SARS‐CoV‐2 in vitro;Caly L;Antiviral Res,2020

5. Molecular docking reveals Ivermectin and Remdesivir as potential repurposed drugs against SARS‐CoV‐2;Eweas AF;Front Microbiol,2021

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ivermectin for treatment of COVID-19: A systematic review and meta-analysis;Heliyon;2024-03

2. Azvudine and mortality in patients with coronavirus disease 2019: A retrospective cohort study;International Immunopharmacology;2023-11

3. Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial;Frontiers in Medicine;2023-05-22

4. Efficacy of Remdesivir and Neutralizing Monoclonal Antibodies in Monotherapy or Combination Therapy in Reducing the Risk of Disease Progression in Elderly or Immunocompromised Hosts Hospitalized for COVID-19: A Single Center Retrospective Study;Viruses;2023-05-19

5. The Clinical Application of Ivermectin in COVID-19;Open Journal of Natural Science;2023